Life Science Company News

Reset
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

New RYBREVANT® (amivantamab-vmjw) Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

Hidden River Announces New Leadership Team Members

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

Broncus Medical (02216.HK) Announces Annual Results for 2022

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

Elemental Machines partners with System-c bioprocess to bring its IoT hardware solutions to the European biopharmaceutical industry

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  Elemental Machines, LLC

EpicentRx Receives Fast Track Designation from the U.S. FDA for Lead Asset, RRx-001, to Prevent/Attenuate Chemotherapy and Radiation Treatment Induced Severe Oral Mucositis

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  EpicentRx Inc.

Henry Gosebruch, Former AbbVie EVP and Chief Strategy Officer, Joins ACELYRIN, INC. Board of Directors

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  ACELYRIN, Inc.

Nevro to Report First Quarter 2023 Financial Results

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  Nevro Corp.

Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  AmerisourceBergen Corporation

23andMe Publishes Inaugural Environmental, Social and Governance Report

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  23andMe, Inc.

Catalent Launches New Oral Developability Assessment and Manufacturing Solution to Advance Targeted Protein Degrader Programs

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

BioCare, Inc. Named to 2023 Financial Times List of The Americas' Fastest Growing Companies

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  Biocare Medical, LLC | BioCareSD

IceCure Medical Reports 2022 Full Year Financial Results & Recent Corporate Developments; Milestone Achievements Expected to Drive Revenue Growth in 2023

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

Beebe Healthcare Selects CareRev to Leverage Delaware's Healthcare Professional Network and Build Flexible Workforce

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

DiabetesSisters Board of Directors Announce Interim CEO

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

Reversion Clarifying Mask Becomes a 2023 NewBeauty Award Winner

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

Metabolon's Metabolomic Platform and Services Cited in More Than 3,000 Peer-Reviewed Articles across Life Sciences, Pharmaceutical/Biotech, and Applied Sciences

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  Metabolon Inc.

MGMA and Jackson Physician Search Extend Partnership to Improve Physician Recruitment for Medical Practices

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023

HARMONY BIOSCIENCES ANNOUNCES ACCELERATED TIMELINE FOR PHASE 3 INTUNE STUDY IN IDIOPATHIC HYPERSOMNIA

Strong momentum in Phase 3 trial; enrollment ahead of schedule;Expects to complete enrollment in the second quarter of 2023, just over one year from trial initiation;Anticipates topline data in the fourth quarter of 2023 Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  Harmony Biosciences Holdings, Inc.

Precigen Announces Further Advancement of UltraCAR-T® Platform with First Patient Dosed in Phase 1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 in Advanced ROR1+ Hematological and Solid Tumors

Read more ››
By: PR Newswire Association LLC. - 29 Mar 2023
Related companies:  Precigen, Inc.
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »